First Affirmative Financial Network Boosts Stake in Danaher Co. (NYSE:DHR)

First Affirmative Financial Network grew its stake in Danaher Co. (NYSE:DHR) by 1.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,451 shares of the conglomerate’s stock after acquiring an additional 94 shares during the quarter. Danaher comprises about 0.7% of First Affirmative Financial Network’s portfolio, making the stock its 24th biggest position. First Affirmative Financial Network’s holdings in Danaher were worth $1,251,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in DHR. FMR LLC lifted its position in shares of Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after buying an additional 3,217,631 shares during the last quarter. Massachusetts Financial Services Co. MA raised its stake in shares of Danaher by 17.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after acquiring an additional 535,254 shares in the last quarter. International Assets Investment Management LLC lifted its position in Danaher by 40,196.5% during the third quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock valued at $119,539,000 after acquiring an additional 428,897 shares during the last quarter. Montrusco Bolton Investments Inc. boosted its stake in Danaher by 30.4% in the third quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock valued at $465,617,000 after acquiring an additional 397,671 shares in the last quarter. Finally, Union Bancaire Privee UBP SA purchased a new position in Danaher in the fourth quarter worth $74,551,000. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

NYSE:DHR opened at $223.12 on Thursday. The company has a 50 day moving average price of $236.09 and a 200-day moving average price of $253.66. Danaher Co. has a 1-year low of $223.00 and a 1-year high of $281.70. The firm has a market cap of $161.16 billion, a price-to-earnings ratio of 42.58, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. During the same quarter last year, the business posted $2.09 EPS. Equities research analysts forecast that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.48%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. Stifel Nicolaus raised their price objective on Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. JPMorgan Chase & Co. lowered their price target on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a report on Tuesday. Raymond James cut their price objective on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a report on Tuesday, January 21st. Robert W. Baird lowered their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday. Finally, Scotiabank began coverage on shares of Danaher in a research note on Monday, December 23rd. They set a “sector perform” rating and a $265.00 price target on the stock. Six analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $284.14.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.